 | • レポートコード：MRC2Q12-17635 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、埋め込み型緑内障デバイスの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に埋め込み型緑内障デバイスのグローバル市場のxxx％を占める「バルブドレナージインプラント」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 埋め込み型緑内障デバイスの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの埋め込み型緑内障デバイス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 埋め込み型緑内障デバイスのグローバル主要プレイヤーには、AbbVie、Santen Pharmaceutical、Johnson and Johnson、Advanced Ophthalmic Innovations (AOI)、New World Medical、Glaukos Corp、Ocular Therapeutix、PolyActivaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 埋め込み型緑内障デバイス市場は、種類と用途によって区分されます。世界の埋め込み型緑内障デバイス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 バルブドレナージインプラント、非バルブドレナージインプラント 【用途別セグメント】 病院、眼科クリニック、外来手術センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 埋め込み型緑内障デバイス製品概要 - 種類別市場（バルブドレナージインプラント、非バルブドレナージインプラント） - 用途別市場（病院、眼科クリニック、外来手術センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の埋め込み型緑内障デバイス販売量予測2017-2028 - 世界の埋め込み型緑内障デバイス売上予測2017-2028 - 埋め込み型緑内障デバイスの地域別販売量 - 埋め込み型緑内障デバイスの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別埋め込み型緑内障デバイス販売量 - 主要メーカー別埋め込み型緑内障デバイス売上 - 主要メーカー別埋め込み型緑内障デバイス価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（バルブドレナージインプラント、非バルブドレナージインプラント） - 埋め込み型緑内障デバイスの種類別販売量 - 埋め込み型緑内障デバイスの種類別売上 - 埋め込み型緑内障デバイスの種類別価格 ・用途別市場規模（病院、眼科クリニック、外来手術センター、その他） - 埋め込み型緑内障デバイスの用途別販売量 - 埋め込み型緑内障デバイスの用途別売上 - 埋め込み型緑内障デバイスの用途別価格 ・北米市場 - 北米の埋め込み型緑内障デバイス市場規模（種類別、用途別） - 主要国別の埋め込み型緑内障デバイス市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの埋め込み型緑内障デバイス市場規模（種類別、用途別） - 主要国別の埋め込み型緑内障デバイス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の埋め込み型緑内障デバイス市場規模（種類別、用途別） - 主要国別の埋め込み型緑内障デバイス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の埋め込み型緑内障デバイス市場規模（種類別、用途別） - 主要国別の埋め込み型緑内障デバイス市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの埋め込み型緑内障デバイス市場規模（種類別、用途別） - 主要国別の埋め込み型緑内障デバイス市場規模（トルコ、サウジアラビア） ・企業情報 AbbVie、Santen Pharmaceutical、Johnson and Johnson、Advanced Ophthalmic Innovations (AOI)、New World Medical、Glaukos Corp、Ocular Therapeutix、PolyActiva ・産業チェーン及び販売チャネル分析 - 埋め込み型緑内障デバイスの産業チェーン分析 - 埋め込み型緑内障デバイスの原材料 - 埋め込み型緑内障デバイスの生産プロセス - 埋め込み型緑内障デバイスの販売及びマーケティング - 埋め込み型緑内障デバイスの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 埋め込み型緑内障デバイスの産業動向 - 埋め込み型緑内障デバイスのマーケットドライバー - 埋め込み型緑内障デバイスの課題 - 埋め込み型緑内障デバイスの阻害要因 ・主な調査結果 |
A glaucoma drainage implant is a small device placed in the eye to treat glaucoma. There are many different ways to treat glaucoma. In addition to conventional and laser surgery, there are a variety of drugs to lower intraocular pressure (IOP). If these methods alone fail, doctors may suggest implants.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Implantable Glaucoma Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Implantable Glaucoma Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Implantable Glaucoma Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Implantable Glaucoma Device include AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Glaukos Corp, Ocular Therapeutix and PolyActiva, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Implantable Glaucoma Device manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Implantable Glaucoma Device market. Further, it explains the major drivers and regional dynamics of the global Implantable Glaucoma Device market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Glaukos Corp
Ocular Therapeutix
PolyActiva
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Implantable Glaucoma Device Segment by Type
Valved Drainage Implants
Non-valved Drainage Implants
Implantable Glaucoma Device Segment by Application
Hospital
Ophthalmology Clinics
Ambulatory Surgery Centers
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Implantable Glaucoma Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Implantable Glaucoma Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Implantable Glaucoma Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Implantable Glaucoma Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Implantable Glaucoma Device sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Implantable Glaucoma Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Implantable Glaucoma Device sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Glaukos Corp, Ocular Therapeutix and PolyActiva, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Implantable Glaucoma Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Implantable Glaucoma Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Implantable Glaucoma Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Implantable Glaucoma Device Product Introduction
1.2 Market by Type
1.2.1 Global Implantable Glaucoma Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Valved Drainage Implants
1.2.3 Non-valved Drainage Implants
1.3 Market by Application
1.3.1 Global Implantable Glaucoma Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Ophthalmology Clinics
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Implantable Glaucoma Device Sales Estimates and Forecasts 2017-2028
2.2 Global Implantable Glaucoma Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Implantable Glaucoma Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Implantable Glaucoma Device Sales by Region
2.4.1 Global Implantable Glaucoma Device Sales by Region (2017-2022)
2.4.2 Global Sales Implantable Glaucoma Device by Region (2023-2028)
2.5 Global Implantable Glaucoma Device Revenue by Region
2.5.1 Global Implantable Glaucoma Device Revenue by Region (2017-2022)
2.5.2 Global Implantable Glaucoma Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Implantable Glaucoma Device Sales by Manufacturers
3.1.1 Global Top Implantable Glaucoma Device Manufacturers by Sales (2017-2022)
3.1.2 Global Implantable Glaucoma Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Implantable Glaucoma Device in 2021
3.2 Global Implantable Glaucoma Device Revenue by Manufacturers
3.2.1 Global Implantable Glaucoma Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Implantable Glaucoma Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Implantable Glaucoma Device Revenue in 2021
3.3 Global Implantable Glaucoma Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Implantable Glaucoma Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Implantable Glaucoma Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Implantable Glaucoma Device Sales by Type
4.1.1 Global Implantable Glaucoma Device Historical Sales by Type (2017-2022)
4.1.2 Global Implantable Glaucoma Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Implantable Glaucoma Device Sales Market Share by Type (2017-2028)
4.2 Global Implantable Glaucoma Device Revenue by Type
4.2.1 Global Implantable Glaucoma Device Historical Revenue by Type (2017-2022)
4.2.2 Global Implantable Glaucoma Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Implantable Glaucoma Device Revenue Market Share by Type (2017-2028)
4.3 Global Implantable Glaucoma Device Price by Type
4.3.1 Global Implantable Glaucoma Device Price by Type (2017-2022)
4.3.2 Global Implantable Glaucoma Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Implantable Glaucoma Device Sales by Application
5.1.1 Global Implantable Glaucoma Device Historical Sales by Application (2017-2022)
5.1.2 Global Implantable Glaucoma Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Implantable Glaucoma Device Sales Market Share by Application (2017-2028)
5.2 Global Implantable Glaucoma Device Revenue by Application
5.2.1 Global Implantable Glaucoma Device Historical Revenue by Application (2017-2022)
5.2.2 Global Implantable Glaucoma Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Implantable Glaucoma Device Revenue Market Share by Application (2017-2028)
5.3 Global Implantable Glaucoma Device Price by Application
5.3.1 Global Implantable Glaucoma Device Price by Application (2017-2022)
5.3.2 Global Implantable Glaucoma Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Implantable Glaucoma Device Market Size by Type
6.1.1 North America Implantable Glaucoma Device Sales by Type (2017-2028)
6.1.2 North America Implantable Glaucoma Device Revenue by Type (2017-2028)
6.2 North America Implantable Glaucoma Device Market Size by Application
6.2.1 North America Implantable Glaucoma Device Sales by Application (2017-2028)
6.2.2 North America Implantable Glaucoma Device Revenue by Application (2017-2028)
6.3 North America Implantable Glaucoma Device Market Size by Country
6.3.1 North America Implantable Glaucoma Device Sales by Country (2017-2028)
6.3.2 North America Implantable Glaucoma Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Implantable Glaucoma Device Market Size by Type
7.1.1 Europe Implantable Glaucoma Device Sales by Type (2017-2028)
7.1.2 Europe Implantable Glaucoma Device Revenue by Type (2017-2028)
7.2 Europe Implantable Glaucoma Device Market Size by Application
7.2.1 Europe Implantable Glaucoma Device Sales by Application (2017-2028)
7.2.2 Europe Implantable Glaucoma Device Revenue by Application (2017-2028)
7.3 Europe Implantable Glaucoma Device Market Size by Country
7.3.1 Europe Implantable Glaucoma Device Sales by Country (2017-2028)
7.3.2 Europe Implantable Glaucoma Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Implantable Glaucoma Device Market Size by Type
8.1.1 Asia Pacific Implantable Glaucoma Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Implantable Glaucoma Device Revenue by Type (2017-2028)
8.2 Asia Pacific Implantable Glaucoma Device Market Size by Application
8.2.1 Asia Pacific Implantable Glaucoma Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Implantable Glaucoma Device Revenue by Application (2017-2028)
8.3 Asia Pacific Implantable Glaucoma Device Market Size by Region
8.3.1 Asia Pacific Implantable Glaucoma Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Implantable Glaucoma Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Implantable Glaucoma Device Market Size by Type
9.1.1 Latin America Implantable Glaucoma Device Sales by Type (2017-2028)
9.1.2 Latin America Implantable Glaucoma Device Revenue by Type (2017-2028)
9.2 Latin America Implantable Glaucoma Device Market Size by Application
9.2.1 Latin America Implantable Glaucoma Device Sales by Application (2017-2028)
9.2.2 Latin America Implantable Glaucoma Device Revenue by Application (2017-2028)
9.3 Latin America Implantable Glaucoma Device Market Size by Country
9.3.1 Latin America Implantable Glaucoma Device Sales by Country (2017-2028)
9.3.2 Latin America Implantable Glaucoma Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Implantable Glaucoma Device Market Size by Type
10.1.1 Middle East and Africa Implantable Glaucoma Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Implantable Glaucoma Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Implantable Glaucoma Device Market Size by Application
10.2.1 Middle East and Africa Implantable Glaucoma Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Implantable Glaucoma Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Implantable Glaucoma Device Market Size by Country
10.3.1 Middle East and Africa Implantable Glaucoma Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Implantable Glaucoma Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Santen Pharmaceutical
11.2.1 Santen Pharmaceutical Corporation Information
11.2.2 Santen Pharmaceutical Overview
11.2.3 Santen Pharmaceutical Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Santen Pharmaceutical Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Santen Pharmaceutical Recent Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Corporation Information
11.3.2 Johnson and Johnson Overview
11.3.3 Johnson and Johnson Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson and Johnson Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson and Johnson Recent Developments
11.4 Advanced Ophthalmic Innovations (AOI)
11.4.1 Advanced Ophthalmic Innovations (AOI) Corporation Information
11.4.2 Advanced Ophthalmic Innovations (AOI) Overview
11.4.3 Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Advanced Ophthalmic Innovations (AOI) Recent Developments
11.5 New World Medical
11.5.1 New World Medical Corporation Information
11.5.2 New World Medical Overview
11.5.3 New World Medical Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 New World Medical Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 New World Medical Recent Developments
11.6 Glaukos Corp
11.6.1 Glaukos Corp Corporation Information
11.6.2 Glaukos Corp Overview
11.6.3 Glaukos Corp Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Glaukos Corp Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Glaukos Corp Recent Developments
11.7 Ocular Therapeutix
11.7.1 Ocular Therapeutix Corporation Information
11.7.2 Ocular Therapeutix Overview
11.7.3 Ocular Therapeutix Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ocular Therapeutix Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ocular Therapeutix Recent Developments
11.8 PolyActiva
11.8.1 PolyActiva Corporation Information
11.8.2 PolyActiva Overview
11.8.3 PolyActiva Implantable Glaucoma Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 PolyActiva Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 PolyActiva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Implantable Glaucoma Device Industry Chain Analysis
12.2 Implantable Glaucoma Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Implantable Glaucoma Device Production Mode & Process
12.4 Implantable Glaucoma Device Sales and Marketing
12.4.1 Implantable Glaucoma Device Sales Channels
12.4.2 Implantable Glaucoma Device Distributors
12.5 Implantable Glaucoma Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Implantable Glaucoma Device Industry Trends
13.2 Implantable Glaucoma Device Market Drivers
13.3 Implantable Glaucoma Device Market Challenges
13.4 Implantable Glaucoma Device Market Restraints
14 Key Findings in The Global Implantable Glaucoma Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Implantable Glaucoma Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Valved Drainage Implants
Table 3. Major Manufacturers of Non-valved Drainage Implants
Table 4. Global Implantable Glaucoma Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Implantable Glaucoma Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Implantable Glaucoma Device Sales by Region (2017-2022) & (K Units)
Table 7. Global Implantable Glaucoma Device Sales Market Share by Region (2017-2022)
Table 8. Global Implantable Glaucoma Device Sales by Region (2023-2028) & (K Units)
Table 9. Global Implantable Glaucoma Device Sales Market Share by Region (2023-2028)
Table 10. Global Implantable Glaucoma Device Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Implantable Glaucoma Device Revenue Market Share by Region (2017-2022)
Table 12. Global Implantable Glaucoma Device Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Implantable Glaucoma Device Revenue Market Share by Region (2023-2028)
Table 14. Global Implantable Glaucoma Device Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Implantable Glaucoma Device Sales Share by Manufacturers (2017-2022)
Table 16. Global Implantable Glaucoma Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Implantable Glaucoma Device Revenue Share by Manufacturers (2017-2022)
Table 18. Implantable Glaucoma Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Implantable Glaucoma Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Implantable Glaucoma Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Glaucoma Device as of 2021)
Table 21. Implantable Glaucoma Device Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Implantable Glaucoma Device Product Offered
Table 23. Date of Manufacturers Enter into Implantable Glaucoma Device Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Implantable Glaucoma Device Sales by Type (2017-2022) & (K Units)
Table 26. Global Implantable Glaucoma Device Sales by Type (2023-2028) & (K Units)
Table 27. Global Implantable Glaucoma Device Sales Share by Type (2017-2022)
Table 28. Global Implantable Glaucoma Device Sales Share by Type (2023-2028)
Table 29. Global Implantable Glaucoma Device Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Implantable Glaucoma Device Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Implantable Glaucoma Device Revenue Share by Type (2017-2022)
Table 32. Global Implantable Glaucoma Device Revenue Share by Type (2023-2028)
Table 33. Implantable Glaucoma Device Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Implantable Glaucoma Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Implantable Glaucoma Device Sales by Application (2017-2022) & (K Units)
Table 36. Global Implantable Glaucoma Device Sales by Application (2023-2028) & (K Units)
Table 37. Global Implantable Glaucoma Device Sales Share by Application (2017-2022)
Table 38. Global Implantable Glaucoma Device Sales Share by Application (2023-2028)
Table 39. Global Implantable Glaucoma Device Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Implantable Glaucoma Device Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Implantable Glaucoma Device Revenue Share by Application (2017-2022)
Table 42. Global Implantable Glaucoma Device Revenue Share by Application (2023-2028)
Table 43. Implantable Glaucoma Device Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Implantable Glaucoma Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Implantable Glaucoma Device Sales by Type (2017-2022) & (K Units)
Table 46. North America Implantable Glaucoma Device Sales by Type (2023-2028) & (K Units)
Table 47. North America Implantable Glaucoma Device Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Implantable Glaucoma Device Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Implantable Glaucoma Device Sales by Application (2017-2022) & (K Units)
Table 50. North America Implantable Glaucoma Device Sales by Application (2023-2028) & (K Units)
Table 51. North America Implantable Glaucoma Device Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Implantable Glaucoma Device Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 54. North America Implantable Glaucoma Device Sales by Country (2023-2028) & (K Units)
Table 55. North America Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Implantable Glaucoma Device Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Implantable Glaucoma Device Sales by Type (2017-2022) & (K Units)
Table 58. Europe Implantable Glaucoma Device Sales by Type (2023-2028) & (K Units)
Table 59. Europe Implantable Glaucoma Device Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Implantable Glaucoma Device Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Implantable Glaucoma Device Sales by Application (2017-2022) & (K Units)
Table 62. Europe Implantable Glaucoma Device Sales by Application (2023-2028) & (K Units)
Table 63. Europe Implantable Glaucoma Device Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Implantable Glaucoma Device Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 66. Europe Implantable Glaucoma Device Sales by Country (2023-2028) & (K Units)
Table 67. Europe Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Implantable Glaucoma Device Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Implantable Glaucoma Device Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Implantable Glaucoma Device Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Implantable Glaucoma Device Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Implantable Glaucoma Device Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Implantable Glaucoma Device Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Implantable Glaucoma Device Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Implantable Glaucoma Device Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Implantable Glaucoma Device Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Implantable Glaucoma Device Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Implantable Glaucoma Device Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Implantable Glaucoma Device Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Implantable Glaucoma Device Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Implantable Glaucoma Device Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Implantable Glaucoma Device Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Implantable Glaucoma Device Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Implantable Glaucoma Device Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Implantable Glaucoma Device Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Implantable Glaucoma Device Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Implantable Glaucoma Device Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Implantable Glaucoma Device Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Implantable Glaucoma Device Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Implantable Glaucoma Device Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Implantable Glaucoma Device Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Implantable Glaucoma Device Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Implantable Glaucoma Device Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Implantable Glaucoma Device Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Implantable Glaucoma Device Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Implantable Glaucoma Device Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Implantable Glaucoma Device Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Implantable Glaucoma Device Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Implantable Glaucoma Device Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Implantable Glaucoma Device Revenue by Country (2023-2028) & (US$ Million)
Table 105. AbbVie Corporation Information
Table 106. AbbVie Description and Major Businesses
Table 107. AbbVie Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. AbbVie Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AbbVie Recent Developments
Table 110. Santen Pharmaceutical Corporation Information
Table 111. Santen Pharmaceutical Description and Major Businesses
Table 112. Santen Pharmaceutical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Santen Pharmaceutical Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Santen Pharmaceutical Recent Developments
Table 115. Johnson and Johnson Corporation Information
Table 116. Johnson and Johnson Description and Major Businesses
Table 117. Johnson and Johnson Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Johnson and Johnson Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Johnson and Johnson Recent Developments
Table 120. Advanced Ophthalmic Innovations (AOI) Corporation Information
Table 121. Advanced Ophthalmic Innovations (AOI) Description and Major Businesses
Table 122. Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Advanced Ophthalmic Innovations (AOI) Recent Developments
Table 125. New World Medical Corporation Information
Table 126. New World Medical Description and Major Businesses
Table 127. New World Medical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. New World Medical Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. New World Medical Recent Developments
Table 130. Glaukos Corp Corporation Information
Table 131. Glaukos Corp Description and Major Businesses
Table 132. Glaukos Corp Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Glaukos Corp Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Glaukos Corp Recent Developments
Table 135. Ocular Therapeutix Corporation Information
Table 136. Ocular Therapeutix Description and Major Businesses
Table 137. Ocular Therapeutix Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Ocular Therapeutix Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Ocular Therapeutix Recent Developments
Table 140. PolyActiva Corporation Information
Table 141. PolyActiva Description and Major Businesses
Table 142. PolyActiva Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. PolyActiva Implantable Glaucoma Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. PolyActiva Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Implantable Glaucoma Device Distributors List
Table 148. Implantable Glaucoma Device Customers List
Table 149. Implantable Glaucoma Device Market Trends
Table 150. Implantable Glaucoma Device Market Drivers
Table 151. Implantable Glaucoma Device Market Challenges
Table 152. Implantable Glaucoma Device Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Implantable Glaucoma Device Product Picture
Figure 2. Global Implantable Glaucoma Device Market Share by Type in 2021 & 2028
Figure 3. Valved Drainage Implants Product Picture
Figure 4. Non-valved Drainage Implants Product Picture
Figure 5. Global Implantable Glaucoma Device Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Ophthalmology Clinics
Figure 8. Ambulatory Surgery Centers
Figure 9. Others
Figure 10. Implantable Glaucoma Device Report Years Considered
Figure 11. Global Implantable Glaucoma Device Sales 2017-2028 (K Units)
Figure 12. Global Implantable Glaucoma Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Implantable Glaucoma Device Revenue 2017-2028 (US$ Million)
Figure 14. Global Implantable Glaucoma Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Implantable Glaucoma Device Sales Market Share by Region (2017-2022)
Figure 16. Global Implantable Glaucoma Device Sales Market Share by Region (2023-2028)
Figure 17. North America Implantable Glaucoma Device Sales YoY (2017-2028) & (K Units)
Figure 18. North America Implantable Glaucoma Device Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Implantable Glaucoma Device Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Implantable Glaucoma Device Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Implantable Glaucoma Device Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Implantable Glaucoma Device Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Implantable Glaucoma Device Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Implantable Glaucoma Device Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Implantable Glaucoma Device Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Implantable Glaucoma Device Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Implantable Glaucoma Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Implantable Glaucoma Device in the World: Market Share by Implantable Glaucoma Device Revenue in 2021
Figure 29. Global Implantable Glaucoma Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Implantable Glaucoma Device Sales Market Share by Type (2017-2028)
Figure 31. Global Implantable Glaucoma Device Revenue Market Share by Type (2017-2028)
Figure 32. Global Implantable Glaucoma Device Sales Market Share by Application (2017-2028)
Figure 33. Global Implantable Glaucoma Device Revenue Market Share by Application (2017-2028)
Figure 34. North America Implantable Glaucoma Device Sales Market Share by Type (2017-2028)
Figure 35. North America Implantable Glaucoma Device Revenue Market Share by Type (2017-2028)
Figure 36. North America Implantable Glaucoma Device Sales Market Share by Application (2017-2028)
Figure 37. North America Implantable Glaucoma Device Revenue Market Share by Application (2017-2028)
Figure 38. North America Implantable Glaucoma Device Sales Share by Country (2017-2028)
Figure 39. North America Implantable Glaucoma Device Revenue Share by Country (2017-2028)
Figure 40. United States Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Implantable Glaucoma Device Sales Market Share by Type (2017-2028)
Figure 43. Europe Implantable Glaucoma Device Revenue Market Share by Type (2017-2028)
Figure 44. Europe Implantable Glaucoma Device Sales Market Share by Application (2017-2028)
Figure 45. Europe Implantable Glaucoma Device Revenue Market Share by Application (2017-2028)
Figure 46. Europe Implantable Glaucoma Device Sales Share by Country (2017-2028)
Figure 47. Europe Implantable Glaucoma Device Revenue Share by Country (2017-2028)
Figure 48. Germany Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 49. France Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Implantable Glaucoma Device Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Implantable Glaucoma Device Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Implantable Glaucoma Device Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Implantable Glaucoma Device Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Implantable Glaucoma Device Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Implantable Glaucoma Device Revenue Share by Region (2017-2028)
Figure 59. China Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 62. India Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Implantable Glaucoma Device Sales Market Share by Type (2017-2028)
Figure 69. Latin America Implantable Glaucoma Device Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Implantable Glaucoma Device Sales Market Share by Application (2017-2028)
Figure 71. Latin America Implantable Glaucoma Device Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Implantable Glaucoma Device Sales Share by Country (2017-2028)
Figure 73. Latin America Implantable Glaucoma Device Revenue Share by Country (2017-2028)
Figure 74. Mexico Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Implantable Glaucoma Device Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Implantable Glaucoma Device Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Implantable Glaucoma Device Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Implantable Glaucoma Device Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Implantable Glaucoma Device Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Implantable Glaucoma Device Revenue Share by Country (2017-2028)
Figure 84. Turkey Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Implantable Glaucoma Device Revenue (2017-2028) & (US$ Million)
Figure 87. Implantable Glaucoma Device Value Chain
Figure 88. Implantable Glaucoma Device Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed